Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
D10964 Omaveloxolone
DG02954 CYP2J2 substrate
D10964 Omaveloxolone
DG01633 CYP3A/CYP3A4 substrate
D10964 Omaveloxolone
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Signaling molecules
Transcription factor
NFE2L2
D10964 Omaveloxolone (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10964
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10964
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10964
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10964